Parallax Volatility Advisers, L.P. Geron Corp Put Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $49,350 - $72,300	15,000 Added 16.67%	105,000 $360,000
Q4 2017 Feb 14, 2018	BUY	$1.8 - $2.32 $162,000 - $208,800	90,000	90,000 $162,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.58B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.